Ng VL, Li R, Loomes KM, Leonis MA, Rudnick DA, Belle SH et al (2016) Outcomes of children with and without hepatic encephalopathy from the pediatric acute liver failure study group. J Pediatr Gastroenterol Nutr 63(3):357–364
Article PubMed PubMed Central Google Scholar
Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP et al (2022) Am J Transpl 22(Suppl 2):204–309OPTN/SRTR 2020 Annual Data Report: Liver
Zoica BS, Deep A (2021) Extracorporeal renal and liver support in pediatric acute liver failure. Pediatr Nephrol 36(5):1119–1128
Tufan Pekkucuksen N, Sigler KE, Akcan Arikan A, Srivaths P (2021) Tandem plasmapheresis and continuous kidney replacement treatment in pediatric patients. Pediatr Nephrol 36(5):1273–1278
Akcan Arikan A, Srivaths P, Himes RW, Tufan Pekkucuksen N, Lam F, Nguyen T et al (2018) Hybrid extracorporeal therapies as a bridge to pediatric liver transplantation. Pediatr Crit Care Med 19(7):e342–e9
Ide K, Muguruma T, Shinohara M, Toida C, Enomoto Y, Matsumoto S et al (2015) Continuous veno-venous hemodiafiltration and plasma exchange in infantile acute liver failure. Pediatr Crit Care Med 16(8):e268–e274
PRISM CPCCRN III Accessed May 26, https://www.cpccrn.org/calculators/prismiiicalculator/
Leteurtre S, Duhamel A, Salleron J, Grandbastien B, Lacroix J, Leclerc F et al (2013) PELOD-2: an update of the pediatric logistic organ dysfunction score. Crit Care Med 41(7):1761–1773
Hafer C, Golla P, Gericke M, Eden G, Beutel G, Schmidt JJ et al (2016) Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study. Int Urol Nephrol 48(1):133–138
Deep A, Stewart CE, Dhawan A, Douiri A (2016) Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 44(10):1910–1919
Article CAS PubMed Google Scholar
Deep A, Alexander EC, Bulut Y, Fitzpatrick E, Grazioli S, Heaton N et al (2022) Advances in medical management of acute liver failure in children: promoting native liver survival. Lancet Child Adolesc Health 6(10):725–737
Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD et al (2020) Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol 73(6):1526–1547
Bachmann C (2003) Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr 162(6):410–416
Burgard P, Kölker S, Haege G, Lindner M, Hoffmann GF (2016) Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders–review and meta-analysis of observational studies published over more than 35 years. J Inherit Metab Dis 39(2):219–229
Ames EG, Luckritz KE, Ahmad A (2020) A retrospective review of outcomes in the treatment of hyperammonemia with renal replacement therapy due to inborn errors of metabolism. Pediatr Nephrol 35(9):1761–1769
Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46(6):1844–1852
Article CAS PubMed Google Scholar
Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the Ninth Special Issue. J Clin Apher 38(2):77–278
Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC et al (2016) High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 64(1):69–78
Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S et al (2019) Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care 23(1):22
Article CAS PubMed PubMed Central Google Scholar
Bai M, Yu Y, Zhao L, Tian X, Zhou M, Jiao J et al (2023) Regional citrate anticoagulation versus no anticoagulation for CKRT in patients with liver failure with increased bleeding risk. Clin J Am Soc Nephrol 19(2):151–160
Thanapongsatorn P, Chaijamorn W, Sirivongrangson P, Tachaboon S, Peerapornratana S, Lumlertgul N et al (2022) Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT. Sci Rep 12(1):1815
Article CAS PubMed PubMed Central Google Scholar
Dos Santos TOC, Dos Santos Ferreira CE, Mangueira CLP, Ammirati AL, Scherer PF, Doher MP et al (2023) Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation. Sci Rep 13(1):20176
Article PubMed PubMed Central Google Scholar
Godfrey E, Desai M, Lam F, Goss J, Rana A, Miloh T (2021) Higher waitlist mortality in pediatric acute-on-chronic liver failure in the UNOS database. J Pediatr Gastroenterol Nutr 72(1):80–87
Possamai LA, Thursz MR, Wendon JA, Antoniades CG (2014) Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol 61(2):439–445
Article CAS PubMed Google Scholar
Alexander EC, Deep A (2022) Therapeutic plasma exchange in children with acute liver failure (ALF): is it time for incorporation into the ALF armamentarium? Pediatr Nephrol 37(8):1775–1788
留言 (0)